Allergic bronchopulmonary aspergillosis in India.
ABPM
allergic bronchopulmonary mycoses
allergic fungal airway disease
allergic sensitization
fungal asthma
fungal sensitization
Journal
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
ISSN: 1365-2222
Titre abrégé: Clin Exp Allergy
Pays: England
ID NLM: 8906443
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
24
03
2023
received:
16
01
2023
accepted:
29
03
2023
medline:
5
7
2023
pubmed:
18
4
2023
entrez:
17
4
2023
Statut:
ppublish
Résumé
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder caused by immune-mediated reactions mounted against Aspergillus fumigatus. The disorder most commonly complicates the course of patients with asthma and cystic fibrosis. From its first description in 1952, significant advances have been made in understanding the pathogenesis and the diagnosis and treatment of ABPA. In the last two decades, most research on ABPA has been published from India. The prevalence and clinical presentation may differ in India from that reported elsewhere. Herein, we review the epidemiology, clinical and radiological characteristics, and distinctive features of ABPA in the Indian subcontinent. To support the review, we surveyed pulmonologists nationwide to understand the challenges in diagnosing and managing ABPA. The survey has yielded valuable insights into the practices associated with the diagnosis and management of ABPA in India.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
751-764Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Chowdhary A, Agarwal K, Kathuria S, Gaur SN, Randhawa HS, Meis JF. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol. 2014;40:30-48.
Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Health. 2019;7:e1269-e1279.
Boaventura R, Sibila O, Agusti A, Chalmers JD. Treatable traits in bronchiectasis. Eur Respir J. 2018;52:1801269.
Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax. 1952;7:317-333.
Shah JR. Allergic bronchopulmonary aspergillosis. J Assoc Physicians India. 1971;19:835-841.
Nath A, Khan A, Hashim Z, Patra JK. Prevalence of Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma at a tertiary care center in North India. Lung India. 2017;34:150-154.
Muthu V, Sehgal IS, Prasad KT, et al. Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly. Mycoses. 2022;65:71-78.
Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy. 2015;45:1765-1778.
Greenberger PA, Bush RK, Demain JG, Luong A, Slavin RG, Knutsen AP. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2014;2:703-708.
Agarwal R. Burden and distinctive character of allergic bronchopulmonary aspergillosis in India. Mycopathologia. 2014;178:447-456.
Agarwal R, Denning DW, Chakrabarti A. Estimation of the burden of chronic and allergic pulmonary aspergillosis in India. PLoS One. 2014;9:e114745.
Agarwal R, Muthu V, Sehgal IS, et al. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in adults with bronchial asthma: a systematic review of global data. J Allergy Clin Immunol Pract. 2023.
Khan ZU, Sandhu RS, Randhawa HS, Menon MP, Dusaj IS. Allergic bronchopulmonary aspergillosis: a study of 46 cases with special reference to laboratory aspects. Scand J Respir Dis. 1976;57:73-87.
Sobti KL, Hoon RS, Dutta RN. Incidence of pulmonary aspergillosis in Indian Armed Forces. J Assoc Physicians India. 1978;26:871-879.
Kumar R, Gaur SN. Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian Pac J Allergy Immunol. 2000;18:181-185.
Maurya V, Gugnani HC, Sarma PU, Madan T, Shah A. Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest. 2005;127:1252-1259.
Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest. 2007;132:1183-1190.
Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med. 2010;104:204-210.
Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses. 2010;53:138-143.
Ghosh T, Dey A, Biswas D, Chatterjee S, Haldar N, Maiti PK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis among asthma patients in eastern India. J Indian Med Assoc. 2010;108:863-865.
Sarkar A, Mukherjee A, Ghoshal AG, Kundu S, Mitra S. Occurrence of allergic bronchopulmonary mycosis in patients with asthma: an Eastern India experience. Lung India. 2010;27:212-216.
Agarwal R, Noel V, Aggarwal AN, Gupta D, Chakrabarti A. Clinical significance of Aspergillus sensitisation in bronchial asthma. Mycoses. 2011;54:e531-e538.
Agarwal R, Maskey D, Aggarwal AN, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One. 2013;8:e61105.
Arora C, Chhina D, Singh A, Gupta R, Kaur J. Aspergillus hypersensitivity and Allergic bronchopulmonary aspergillosis in bronchial asthma patients. Int J Pharm Res Biosci. 2015;4:121-124.
Kalaiyarasan JAK, Puri M, Tayal D, Singhal R, Sarin R. Prevalence of allergic bronchopulmonary aspergillosis in asthmatic patients: a prospective institutional study. Indian J Tuberc. 2018;65:285-289.
Bhankhur D, Singla N, Aggarwal D, Chander J. Prevalence of allergic bronchopulmonary aspergillosis among patients with severe bronchial asthma in a tertiary care hospital in Northern India. Indian J Pathol Microbiol. 2019;62:111-113.
Shahul A, Govindaraj V, Kumar SV, Negi VS, Pandit V, Chauhan AS. Allergic bronchopulmonary aspergillosis in acute severe asthma - a cross-sectional study. J Clin Diag Res. 2020;14:OC12-OC15.
Harikrishnan G, Vaiyakkani G, Sundaravadanam S. Allergic bronchopulmonary aspergillosis in resistant asthmatics. Int J Adv Med. 2021;8:1804-1811.
Saxena P, Choudhary H, Muthu V, et al. Which are the optimal criteria for the diagnosis of Allergic bronchopulmonary aspergillosis? A latent class analysis. J Allergy Clin Immunol Pract. 2021;9:328-335.e1.
Soundappan K, Muthu V, Dhooria S, et al. Population prevalence of allergic bronchopulmonary aspergillosis in asthma: an epidemiological study of 43,261 participants from North India. Clin Exp Allergy. 2023, in press. doi:10.1111/cea.14299
Donnelly SC, McLaughlin H, Bredin CP. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88. Ir J Med Sci. 1991;160:288-290.
Novey HS. Epidemiology of allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am. 1998;18:641-653.
Global Asthma Network. The global asthma report 2018. Accessed December 9, 2022. http://www.globalasthmareport.org/resources/global_asthma_report_2018.pdf
Arroyave WD, Rabito FA, Carlson JC. The relationship between a specific IgE level and asthma outcomes: results from the 2005-2006 National Health and Nutrition Examination Survey. J Allergy Clin Immunol Pract. 2013;1:501-508.
Muthu V, Sehgal IS, Prasad KT, et al. Allergic bronchopulmonary aspergillosis (ABPA) sans asthma: a distinct subset of ABPA with a lesser risk of exacerbation. Med Mycol. 2020;58:260-263.
Muthu V, Agarwal R. A report of a successfully treated case of ABPA in an HIV-infected individual. BMJ Case Rep. 2014;2014:bcr2014206236.
Sehgal IS, Dhooria S, Bal A, Agarwal R. Allergic bronchopulmonary aspergillosis in an adult with Kartagener syndrome. BMJ Case Rep. 2015;2015.
Sehgal IS, Dhooria S, Behera D, Agarwal R. Allergic bronchopulmonary aspergillosis complicating Swyer-James-Macleod's syndrome: case report and review of literature. Eur Ann Allergy Clin Immunol. 2016;48:99-102.
Agarwal R, Srinivas R, Jindal SK. Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease. Mycoses. 2008;51:83-85.
Agarwal R, Hazarika B, Gupta D, Aggarwal AN, Chakrabarti A, Jindal SK. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol. 2010;48:988-994.
Agarwal R, Bhogal S, Choudhary H, et al. Aspergillus sensitisation in bidi smokers with and without chronic obstructive lung disease. Mycoses. 2017;60:381-386.
Muthu V, Prasad KT, Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Obstructive lung diseases and allergic bronchopulmonary aspergillosis. Curr Opin Pulm Med. 2021;27:105-112.
Agarwal R, Devi D, Gupta D, Chakrabarti A. A questionnaire-based study on the role of environmental factors in allergic bronchopulmonary aspergillosis. Lung India. 2014;31:232-236.
Nayak BK. Prevalence of fungal spores in rural and urban environments of Pondicherry region during 2013. Adv Appl Sci Res. 2014;5:232-236.
McCarthy DS, Pepys S. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 1. Clinical features. Clin Allergy. 1971;1:261-286.
Shah A, Kala J, Sahay S, Panjabi C. Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol. 2008;101:363-369.
Overton NL, Denning DW, Bowyer P, Simpson A. Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study. Allergy Asthma Clin Immunol. 2016;12:47.
Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2003;111:1001-1007.
Kaur S, Gupta VK, Shah A, Thiel S, Sarma PU, Madan T. Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol. 2006;143:414-419.
Kanaujia R, Arora A, Chakrabarti A, Rudramurthy SM, Agarwal R. Occurrence of cystic fibrosis transmembrane conductance regulator gene mutations in patients with allergic bronchopulmonary aspergillosis complicating asthma. Mycopathologia. 2022;187:147-155.
Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest. 2006;130:442-448.
Behera D, Guleria R, Jindal SK, Chakrabarti A, Panigrahi D. Allergic bronchopulmonary aspergillosis: a retrospective study of 35 cases. Indian J Chest Dis Allied Sci. 1994;36:173-179.
Godet C, Couturaud F, Marchand-Adam S, et al. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial. Eur Respir J. 2022;59:2102218.
Oguma T, Taniguchi M, Shimoda T, et al. Allergic bronchopulmonary aspergillosis in Japan: a nationwide survey. Allergol Int. 2018;67:79-84.
Zeng Y, Xue X, Cai H, et al. Clinical characteristics and prognosis of allergic bronchopulmonary aspergillosis: a retrospective cohort study. J Asthma Allergy. 2022;15:53-62.
Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One. 2010;5:e15346.
Agarwal R, Aggarwal AN, Garg M, Saikia B, Chakrabarti A. Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses. 2014;57:659-663.
Sehgal IS, Agarwal R. Specific IgE is better than skin testing for detecting Aspergillus sensitization and allergic bronchopulmonary aspergillosis in asthma. Chest. 2015;147:e194.
Schwartz HJ. Problems with skin testing in patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol. 1995;75:533-535.
Agarwal R, Aggarwal AN, Sehgal IS, Dhooria S, Behera D, Chakrabarti A. Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis. Mycoses. 2016;59:1-6.
Sehgal IS, Dhooria S, Prasad KT, Muthu V, Aggarwal AN, Agarwal R. Comparative diagnostic accuracy of immunoprecipitation versus immunoassay methods for detecting Aspergillus fumigatus-specific IgG in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis. Mycoses. 2022;65:866-876.
Hsiao CW, Yen TH, Wu YC, et al. Comparison of Aspergillus-specific antibody cut-offs for the diagnosis of aspergillosis. Front Microbiol. 2022;13:1060727.
Hamada Y, Fukutomi Y, Nakatani E, et al. Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis. Allergol Int. 2021;70:74-80.
Agarwal R, Dua D, Choudhary H, et al. Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis. Mycoses. 2017;60:33-39.
Piarroux RP, Romain T, Martin A, et al. Multicenter evaluation of a novel immunochromatographic test for anti-aspergillus IgG detection. Front Cell Infect Microbiol. 2019;9:12.
Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850-873.
Agarwal R, Khan A, Aggarwal AN, et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis. J Infect Public Health. 2011;4:235-243.
Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4:141-150.
Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Pictorial essay: allergic bronchopulmonary aspergillosis. Indian J Radiol Imaging. 2011;21:242-252.
Agarwal R, Aggarwal AN, Gupta D. High-attenuation mucus in allergic bronchopulmonary aspergillosis: another cause of diffuse high-attenuation pulmonary abnormality. AJR Am J Roentgenol. 2006;186:904.
Agarwal R. High attenuation mucoid impaction in allergic bronchopulmonary aspergillosis. World J Radiol. 2010;2:41-43.
Phuyal S, Garg MK, Agarwal R, et al. High-attenuation mucus impaction in patients with Allergic bronchopulmonary aspergillosis: objective criteria on high-resolution computed tomography and correlation with serologic parameters. Curr Probl Diagn Radiol. 2016;45:168-173.
Agarwal R, Aggarwal AN, Gupta D, Bal A, Das A. A rare cause of miliary nodules - Allergic bronchopulmonary aspergillosis. Br J Radiol. 2009;82:e151-e154.
Shah A, Kala J, Sahay S. Allergic bronchopulmonary aspergillosis with hilar adenopathy in a 42-month-old boy. Pediatr Pulmonol. 2007;42:747-748.
Agarwal R, Reddy C, Gupta D. An unusual cause of hilar lymphadenopathy. Lung India. 2006;23:90-92.
Madan K, Bal A, Agarwal R. Pleural effusion in a patient with allergic bronchopulmonary aspergillosis. Respir Care. 2012;57:1509-1513.
Agarwal R, Aggarwal AN, Gupta N, Gupta D. A rare cause of acute respiratory failure - allergic bronchopulmonary aspergillosis. Mycoses. 2011;54:e223-e227.
Agarwal R, Srinivas R, Agarwal AN, Saxena AK. Pulmonary masses in allergic bronchopulmonary aspergillosis: mechanistic explanations. Respir Care. 2008;53:1744-1748.
Campbell MJ, Clayton YM. Bronchopulmonary aspergillosis. A correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis. Am Rev Respir Dis. 1964;89:186-196.
McCarthy DS, Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy. 1971;1:415-432.
Chakrabarti A, Sethi S, Raman DS, Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses. 2002;45:295-299.
Sehgal IS, Choudhary H, Dhooria S, et al. Prevalence of sensitization to Aspergillus flavus in patients with allergic bronchopulmonary aspergillosis. Med Mycol. 2019;57:270-276.
Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011;52:1123-1129.
Klaassen CH, de Valk HA, Curfs-Breuker IM, Meis JF. Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands. J Antimicrob Chemother. 2010;65:901-905.
Agarwal R, Muthu V, Sehgal IS, et al. A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2022;59:2101787.
Agarwal R, Muthu V. Prednisolone plus itraconazole in acute-stage allergic brchopulmonary aspergillosis complicating asthma. Eur Respir J. 2021.
Malo JL, Hawkins R, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings. Thorax. 1977;32:254-261.
Nichols D, Dopico GA, Braun S, Imbeau S, Peters ME, Rankin J. Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis. Am J Med. 1979;67:631-637.
Hill AT, Welham SA, Sullivan AL, Loebinger MR. Updated BTS adult bronchiectasis guideline 2018: a multidisciplinary approach to comprehensive care. Thorax. 2019;74:1-3.
Chalmers JD. Bronchiectasis in adults: epidemiology, assessment of severity and prognosis topical collection on bronchiectasis. Curr Pulmonol Rep. 2015;4:142-151.
Agarwal R, Sehgal IS, Muthu V, Dhooria S, Prasad KT, Aggarwal AN. Estimating the minimal important difference in FEV(1) for patients with allergic bronchopulmonary aspergillosis. Eur Respir J. 2022;60:2201242.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1-e38.
Agarwal R, Aggarwal AN, Sehgal IS, Dhooria S, Behera D, Chakrabarti A. Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis. Mycoses. 2015;58:408-412.
Fukutomi Y, Tanimoto H, Yasueda H, Taniguchi M. Serological diagnosis of allergic bronchopulmonary mycosis: progress and challenges. Allergol Int. 2016;65:30-36.
Muthu V, Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: a systematic review and diagnostic test accuracy meta-analysis. Clin Exp Allergy. 2018;48:1107-1136.
World Health Organization and International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-committee. http://www.allergen.org/search.php?Species=Aspergillus%20fumigatus
Muthu V, Singh P, Choudhary H, et al. Role of recombinant Aspergillus fumigatus antigens in diagnosing Aspergillus sensitisation among asthmatics. Mycoses. 2020;63:928-936.
Muthu V, Singh P, Choudhary H, et al. Diagnostic cutoffs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2020;8:579-587.
Prasad KT, Muthu V, Sehgal IS, et al. The utility of the basophil activation test in differentiating asthmatic subjects with and without allergic bronchopulmonary aspergillosis. Mycoses. 2020;63:588-595.
Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Aggarwal AN. Allergic bronchopulmonary aspergillosis. Clin Chest Med. 2022;43:99-125.
Agarwal R, Sehgal IS, Dhooria S, et al. Allergic bronchopulmonary aspergillosis. Indian J Med Res. 2020;151:529-549.
Agarwal R, Sehgal IS, Dhooria S, Aggarwal AN. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Rev Respir Med. 2016;10:1317-1334.
Dhooria S, Agarwal R. Diagnosis of allergic bronchopulmonary aspergillosis: a case-based approach. Future Microbiol. 2014;9:1195-1208.
Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977;86:405-414.
Dhooria S, Sehgal IS, Muthu V, Agarwal R. Treatment of allergic bronchopulmonary aspergillosis: from evidence to practice. Future Microbiol. 2020;15:365-376.
Nazik Bahçecioğlu S, Türk M, Paçacı Çetin G, Yılmaz İ. The adequacy of current diagnostic criteria for making a diagnosis of ABPA. Tuberk Toraks. 2022;70:141-148.
Agarwal R, Saxena P, Muthu V, et al. Evaluation of simpler criteria for diagnosing Allergic bronchopulmonary aspergillosis complicating asthma. Front Cell Infect Microbiol. 2022;12:861866.
Asano K, Hebisawa A, Ishiguro T, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol. 2021;147:1261-68.e5.
Greenberger PA, Miller TP, Roberts M, Smith LL. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy. 1993;70:333-338.
Agarwal R, Singh N, Gupta D. Pulmonary hypertension as a presenting manifestation of allergic bronchopulmonary aspergillosis. Indian J Chest Dis Allied Sci. 2009;51:37-40.
Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342:756-762.
Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003;111:952-957.
Currie DC, Lueck C, Milburn HJ, et al. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax. 1990;45:447-450.
Voskamp AL, Gillman A, Symons K, et al. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2015;3:192-199.
Agarwal R, Aggarwal AN, Dhooria S, et al. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2016;47:490-498.
Ram B, Aggarwal AN, Dhooria S, et al. A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis. J Asthma. 2016;53:517-524.
Agarwal R, Dhooria S, Singh Sehgal I, et al. A randomized trial of itraconazole vs prednisolone in acute-stage Allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153:656-664.
Agarwal R, Dhooria S, Sehgal IS, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2018;52:1801159.
Dodamani MH, Muthu V, Thakur R, et al. A randomised trial of vitamin D in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Mycoses. 2019;62:320-327.
Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014;69:1162-1176.
Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216:S436-s44.
Pasqualotto AC, Denning DW. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance. Int J Antimicrob Agents. 2007;30:93-94.
Sehgal IS, Vinay K, Dhooria S, et al. Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis. Mycoses. 2023, in press. doi:10.1111/myc.13583
Sardana K, Khurana A, Panesar S, Singh A. An exploratory pilot analysis of the optimal pellet number in 100 mg of itraconazole capsule to maximize the surface area to satisfy the Noyes-Whitney equation. J Dermatolog Treat. 2021;32:788-794.
Sardana K, Khurana A, Singh A, Gautam RK. A pilot analysis of morphometric assessment of itraconazole brands using dermoscopy and its relevance in the current scenario. Indian Dermatol Online J. 2018;9:426-431.
Lebrun-Vignes B, Archer VC, Diquet B, et al. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br J Clin Pharmacol. 2001;51:443-450.
Abuzneid YS, Yaghi Y, Madia A, et al. Misdiagnosis of persistent asthma of a patient suffering from acute bronchopulmonary aspergillosis (ABPA). Ann Med Surg (Lond). 2021;68:102696.
Szecsi PB, Stender S. Comparison of immunoglobulin E measurements on IMMULITE and ImmunoCAP in samples consisting of allergen-specific mouse-human chimeric monoclonal antibodies towards allergen extracts and four recombinant allergens. Int Arch Allergy Immunol. 2013;162:131-134.